Management Options and Factors Affecting Control of a Common Waterhemp ( Amaranthus rudis

Repeated use of protox-inhibiting herbicides has resulted in a common waterhemp (Amaranthus rudis Sauer) biotype that survived lactofen applied up to 10 times the labeled rate. Field and greenhouse research evaluated control options for this biotype of common waterhemp. In the field, PRE applications of flumioxazin at 72 g ai ha−1, sulfentrazone at 240 g ai ha−1, and isoxaflutole at 70 g ai ha−1 controlled common waterhemp >90% up to 6 weeks after treatment. POST applications of fomesafen at 330 g ai ha−1, lactofen at 220 g ai ha−1, and acifluorfen at 420 g ai ha−1 resulted in <60% visual control of common waterhemp, but differences were detected among herbicides. In the greenhouse, glyphosate was the only herbicide that controlled protox resistant waterhemp. The majority of herbicide activity from POST flumioxazin, fomesafen, acifluorfen, and lactofen was from foliar placement, but control was less than 40% regardless of placement. Control of common waterhemp seeded at weekly intervals after herbicide treatment with flumioxazin, fomesafen, sulfentrazone, atrazine, and isoxaflutole exceeded 85% at 0 weeks after herbicide application (WAHA), while control with isoxaflutole was greater than 60% 6 WAHA. PRE and POST options for protox-resistant common waterhemp are available to manage herbicide resistance

Academic Accounting Salaries in the Southwest: A Revisitation and Exploration

This study examines the faculty located in the Southwest Region of the American Accounting Association to ascertain salary determinants as well explore salary compression and inversion. This study finds there are differences among faculty salaries based on longevity, institutional type and size. Typically larger, public institutions pay higher salaries. Further this study finds that salary, perceived salary compared to others, institutional longevity, marital status, institutional type and size are significantly associated with faculty’s gender

Pharmacist-Administered Influenza Vaccination in Children and Corresponding Regulations

In our retrospective cohort study, we evaluated trends in pharmacist-administered pediatric influenza vaccination rates in the United States and corresponding state-level pharmacist pediatric vaccination authorization models, including minimum age requirements, vaccination protocols, and/or prescription requirements. An administrative health claims database was used to capture influenza vaccinations in children less than 18 years old with 1 year of continuous enrollment and joinpoint regression was used to assess trends. Of the 3,937,376 pediatric influenza vaccinations identified over the study period, only 3.2% were pharmacist-administered (87.7% pediatrician offices, 2.3% convenience care clinics, 0.8% emergency care, and 6.0% other locations). Pharmacist-administered pediatric influenza vaccination was more commonly observed in older children (mean age 12.65 ± 3.26 years) and increased significantly by 19.2% annually over the study period (95% confidence interval 9.2%-30.2%, p \u3c 0.05). The Northeast, with more restrictive authorization models, represented only 2.2% (n = 2816) of all pharmacist-administered pediatric influenza vaccinations. Utilization of pharmacist-administered pediatric influenza vaccination remains low. Providing children with greater access to vaccination with less restrictions may increase overall vaccination rates. Due to the COVID-19 pandemic and the Public Readiness and Emergency Preparedness Act, pharmacists will play a major role in vaccinating children

Brief Home-Based Data Collection of Low Frequency Behaviors

Data-based decision making, an important component of positive behavior support, can be difficult in brief in-home therapy due to the limited amount of time a therapist has to directly observe the child. This difficulty is exacerbated when problem behavior occurs infrequently. When a therapist cannot reliably observe problem behavior, it is often necessary to rely on parental report. The current study evaluated three approaches for parental report of low frequency problem behavior: antecedent-behavior-consequence records, incident data, and interview. Each method was analyzed with clients in home-based therapy with 2-hour weekly appointments. All clients exhibited low-frequency (i.e., less than daily) and high-intensity (i.e., causes physical harm to self/others, damage to the environment, or severe decrement to family’s quality of life) problem behavior. The treatment goal for all clients was to reduce problem behavior (most commonly aggression, disruption, or self-injury). The number of instances of problem behavior captured by each method of data-collection, quality of the data (i.e., ability to detect treatment effects using the data), and therapist and parent acceptability of each measure were analyzed. Results are discussed in terms of the relative advantages and disadvantages of each measure, clinical application of the methods, and avenues for future research

Differential 5-Year Brain Atrophy Rates in Cognitively Declining and Stable \u3cem\u3eAPOE\u3c/em\u3e-Ε4 Elders

Objective: The apolipoprotein E (APOE) ε4 allele is the most important genetic risk factor for late-onset Alzheimer’s disease. Many ε4 carriers, however, never develop Alzheimer’s disease. The purpose of this study is to characterize the variability in phenotypic expression of the ε4 allele, as measured by the longitudinal trajectory of cognitive test scores and MRI brain volumes, in cognitively intact elders. Method: Healthy older adults, ages 65–85, participated in a 5-year longitudinal study that included structural MRI and cognitive testing administered at baseline and at 1.5 and 5 years postenrollment. Participants included 22 ε4 noncarriers, 15 ε4 carriers who experienced a decline in cognition over the 5-year interval, and 11 ε4 carriers who remained cognitively stable. Results: No baseline cognitive or volumetric group differences were observed. Compared to noncarriers, declining ε4 carriers had significantly greater rates of atrophy in left (p = .001, Cohen’s d = .691) and right (p = .003, d = .622) cortical gray matter, left (p = .003, d = .625) and right (p = .020, d = .492) hippocampi, and greater expansion of the right inferior lateral ventricle (p \u3c .001, d = .751) over 5 years. Conclusions: This study illustrates the variability in phenotypic expression of the ε4 allele related to neurodegeneration. Specifically, only those individuals who exhibited longitudinal declines in cognitive function experienced concomitant changes in brain volume. Future research is needed to better understand the biological and lifestyle factors that may influence the expression of the ε4 allele. (PsycINFO Database Record (c) 2018 APA, all rights reserved

The Grizzly, February 5, 2004

Take Notice of New Member Education Standards • AES Team with Upromise to Help Ease the Repayment of Student Loans • Unpredictable Democratic Primaries • Myrin Library Update: Media Services Re-opens • Opinions: New Member Education: Yes or No?; Is Blackboard Worth the Fuss?; Max and Erma\u27s New Hot Spot in Town • Men\u27s Lacrosse: 2004 Season Outlookhttps://digitalcommons.ursinus.edu/grizzlynews/1552/thumbnail.jp

Role of Natural Killer Cells in Innate Protection against Lethal Ebola Virus Infection

Ebola virus is a highly lethal human pathogen and is rapidly driving many wild primate populations toward extinction. Several lines of evidence suggest that innate, nonspecific host factors are potentially critical for survival after Ebola virus infection. Here, we show that nonreplicating Ebola virus-like particles (VLPs), containing the glycoprotein (GP) and matrix protein virus protein (VP)40, administered 1–3 d before Ebola virus infection rapidly induced protective immunity. VLP injection enhanced the numbers of natural killer (NK) cells in lymphoid tissues. In contrast to live Ebola virus, VLP treatment of NK cells enhanced cytokine secretion and cytolytic activity against NK-sensitive targets. Unlike wild-type mice, treatment of NK-deficient or -depleted mice with VLPs had no protective effect against Ebola virus infection and NK cells treated with VLPs protected against Ebola virus infection when adoptively transferred to naive mice. The mechanism of NK cell–mediated protection clearly depended on perforin, but not interferon-γ secretion. Particles containing only VP40 were sufficient to induce NK cell responses and provide protection from infection in the absence of the viral GP. These findings revealed a decisive role for NK cells during lethal Ebola virus infection. This work should open new doors for better understanding of Ebola virus pathogenesis and direct the development of immunotherapeutics, which target the innate immune system, for treatment of Ebola virus infection

Postglacial migration shaped the genomic diversity and global distribution of the wild ancestor of lager-brewing hybrids

The wild, cold-adapted parent of hybrid lager-brewing yeasts, Saccharomyces eubayanus, has a complex and understudied natural history. The exploration of this diversity can be used both to develop new brewing applications and to enlighten our understanding of the dynamics of yeast evolution in the wild. Here, we integrate whole genome sequence and phenotypic data of 200 S. eubayanus strains, the largest collection known to date. S. eubayanus has a multilayered population structure, consisting of two major populations that are further structured into six subpopulations. Four of these subpopulations are found exclusively in the Patagonian region of South America; one is found predominantly in Patagonia and sparsely in Oceania and North America; and one is specific to the Holarctic ecozone. Plant host associations differed between subpopulations and between S. eubayanus and its sister species, Saccharomyces uvarum. S. eubayanus is most abundant and genetically diverse in northern Patagonia, where some locations harbor more genetic diversity than is found outside of South America, suggesting that northern Patagonia east of the Andes was a glacial refugium for this species. All but one subpopulation shows isolation-by-distance, and gene flow between subpopulations is low. However, there are strong signals of ancient and recent outcrossing, including two admixed lineages, one that is sympatric with and one that is mostly isolated from its parental populations. Using our extensive biogeographical data, we build a robust model that predicts all known and a handful of additional regions of the globe that are climatically suitable for S. eubayanus, including Europe where host accessibility and competitive exclusion by other Saccharomyces species may explain its continued elusiveness. We conclude that this industrially relevant species has rich natural diversity with many factors contributing to its complex distribution and natural history.Fil: Langdon, Quinn K.. University of Wisconsin; Estados UnidosFil: Peris, David. University of Wisconsin; Estados Unidos. Consejo Superior de Investigaciones Científicas. Instituto de Agroquímica y Tecnología de Alimentos; EspañaFil: Eizaguirre, Juan Ignacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Patagonia Norte. Instituto Andino Patagónico de Tecnologías Biológicas y Geoambientales. Universidad Nacional del Comahue. Instituto Andino Patagónico de Tecnologías Biológicas y Geoambientales; ArgentinaFil: Opulente, Dana A.. University of Wisconsin; Estados UnidosFil: Buh, Kelly V.. University of Wisconsin; Estados UnidosFil: Sylvester, Kayla. University of Wisconsin; Estados UnidosFil: Jarzyna, Martin. University of Wisconsin; Estados UnidosFil: Rodríguez, María Eugenia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Patagonia Norte. Instituto de Investigación y Desarrollo en Ingeniería de Procesos, Biotecnología y Energías Alternativas. Universidad Nacional del Comahue. Instituto de Investigación y Desarrollo en Ingeniería de Procesos, Biotecnología y Energías Alternativas; ArgentinaFil: Lopes, Christian Ariel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Patagonia Norte. Instituto de Investigación y Desarrollo en Ingeniería de Procesos, Biotecnología y Energías Alternativas. Universidad Nacional del Comahue. Instituto de Investigación y Desarrollo en Ingeniería de Procesos, Biotecnología y Energías Alternativas; ArgentinaFil: Libkind Frati, Diego. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Patagonia Norte. Instituto Andino Patagónico de Tecnologías Biológicas y Geoambientales. Universidad Nacional del Comahue. Instituto Andino Patagónico de Tecnologías Biológicas y Geoambientales; ArgentinaFil: Hittinger, Chris. University of Wisconsin; Estados Unido